
    
      According to different location of the primary lesionï¼Œthe subject can be allocated to two
      sub-groups:

      The patient with upper or middle thoracic esophageal cancer may be assigned to two
      field(T)-total mediastinal lymphadenectomy group,which is control group in this study or
      three field lymphadenectomy-Abdominal + mediastinal + cervical lymphadenectomy group,which is
      study group in this study randomly.

      After the operation,the patient whose primary lesion is completely(R0) resected will be
      assigned to adjuvant chemotherapy group or interview group randomly.
    
  